{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T12:03:18Z","timestamp":1794657798112,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T00:00:00Z","timestamp":1301529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Anesth\/J Can Anesth"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s12630-011-9494-6","type":"journal-article","created":{"date-parts":[[2011,3,30]],"date-time":"2011-03-30T17:19:49Z","timestamp":1301505589000},"page":"504-513","source":"Crossref","is-referenced-by-count":52,"title":["Ryanodine receptor type 1 gene mutations found in the Canadian malignant hyperthermia population","Observation de mutations g\u00e9n\u00e9tiques des r\u00e9cepteurs de la ryanodine de type 1 chez les patients canadiens atteints d\u2019hyperthermie maligne"],"prefix":"10.1007","volume":"58","author":[{"given":"Natasha","family":"Kraeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Riazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Loke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Frodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Lou","family":"Crossan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kraev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,31]]},"reference":[{"key":"9494_CR1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/BF03004695","volume":"17","author":"BA Britt","year":"1970","unstructured":"Britt BA, Kalow W. Malignant hyperthermia: aetiology unknown. Can Anaesth Soc J 1970; 17: 316-30.","journal-title":"Can Anaesth Soc J"},{"key":"9494_CR2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","volume":"2","author":"H Rosenberg","year":"2007","unstructured":"Rosenberg H, Davis M, James D, Pollock N, Stowell K. Malignant hyperthermia. Orphanet J Rare Dis 2007; 2: 21.","journal-title":"Orphanet J Rare Dis"},{"key":"9494_CR3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1589759","volume":"256","author":"DH MacLennan","year":"1992","unstructured":"MacLennan DH, Phillips MS. Malignant hyperthermia. Science 1992; 256: 789-94.","journal-title":"Science"},{"key":"9494_CR4","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0005-2736(87)90434-2","volume":"897","author":"JR Mickelson","year":"1987","unstructured":"Mickelson JR, Ross JA, Hyslop RJ, Gallant EM, Louis CF. Skeletal muscle sarcolemma in malignant hyperthermia: evidence for a defect in calcium regulation. Biochim Biophys Acta 1987; 897: 364-76.","journal-title":"Biochim Biophys Acta"},{"key":"9494_CR5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/bja\/34.6.395","volume":"34","author":"MA Denborough","year":"1962","unstructured":"Denborough MA, Forster JF, Lovell RR, Maplestone PA, Villiers JD. Anaesthetic deaths in a family. Br J Anaesth 1962; 34: 395-6.","journal-title":"Br J Anaesth"},{"key":"9494_CR6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","volume":"27","author":"R Robinson","year":"2006","unstructured":"Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins P. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat 2006; 27: 977-89.","journal-title":"Hum Mutat"},{"key":"9494_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0304-4157(94)00014-5","volume":"1241","author":"W Melzer","year":"1995","unstructured":"Melzer W, Herrmann-Frank A, Luttgau HC. The role of Ca2+ ions in excitation\u2013contraction coupling of skeletal muscle fibres. Biochim Biophys Acta 1995; 1241: 59-116.","journal-title":"Biochim Biophys Acta"},{"key":"9494_CR8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00000542-200503000-00007","volume":"102","author":"N Sambuughin","year":"2005","unstructured":"Sambuughin N, Holley H, Muldoon S, et al. Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the North American population. Anesthesiology 2005; 102: 515-21.","journal-title":"Anesthesiology"},{"key":"9494_CR9","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/humu.9442","volume":"27","author":"L Galli","year":"2006","unstructured":"Galli L, Orrico A, Lorenzini S, et al. Frequency, localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia. Hum Mutat 2006; 27: 830.","journal-title":"Hum Mutat"},{"key":"9494_CR10","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/humu.20878","volume":"30","author":"S Levano","year":"2009","unstructured":"Levano S, Vukcevic M, Singer M, et al. Increasing the number of diagnostic mutations in malignant hyperthermia. Hum Mutat 2009; 30: 590-8.","journal-title":"Hum Mutat"},{"key":"9494_CR11","doi-asserted-by":"crossref","unstructured":"Tammaro A, Di Martino A, Bracco A, et al. Novel missense mutations and unexpected multiple changes of RYR1 gene in 75 malignant hyperthermia families. Clin Genet 2010. DOI: 10.1111\/j.1399-0004.2010.01493.x .","DOI":"10.1111\/j.1399-0004.2010.01493.x"},{"key":"9494_CR12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/geno.1996.0238","volume":"34","author":"MS Phillips","year":"1996","unstructured":"Phillips MS, Fujii J, Khanna VK, et al. The structural organization of the human skeletal muscle ryanodine receptor (RYR1) gene. Genomics 1996; 34: 24-41.","journal-title":"Genomics"},{"key":"9494_CR13","doi-asserted-by":"crossref","unstructured":"MacLennan DH, Zvaritch E. Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum. Biochim Biophys Acta 2010. DOI: 10.1016\/j.bbamcr.2010.11.009 .","DOI":"10.1016\/j.bbamcr.2010.11.009"},{"key":"9494_CR14","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/515454","volume":"60","author":"N Monnier","year":"1997","unstructured":"Monnier N, Procaccio V, Stieglitz P, Lunardi J. Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am J Hum Genet 1997; 60: 1316-25.","journal-title":"Am J Hum Genet"},{"key":"9494_CR15","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00000542-200211000-00007","volume":"97","author":"N Monnier","year":"2002","unstructured":"Monnier N, Krivosic-Horber R, Payen JF, et al. Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility. Anesthesiology 2002; 97: 1067-74.","journal-title":"Anesthesiology"},{"key":"9494_CR16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1399-0004.2001.590306.x","volume":"59","author":"SL Stewart","year":"2001","unstructured":"Stewart SL, Hogan K, Rosenberg H, Fletcher JE. Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia. Clin Genet 2001; 59: 178-84.","journal-title":"Clin Genet"},{"key":"9494_CR17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s12630-010-9314-4","volume":"57","author":"PJ Toppin","year":"2010","unstructured":"Toppin PJ, Chandy TT, Ghanekar A, Kraeva N, Beattie WS, Riazi S. A report of fulminant malignant hyperthermia in a patient with a novel mutation of the CACNA1S gene. Can J Anesth 2010; 57: 689-93.","journal-title":"Can J Anesth"},{"key":"9494_CR18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2350-10-104","volume":"10","author":"D Carpenter","year":"2009","unstructured":"Carpenter D, Ringrose C, Leo V, et al. The role of CACNA1S in predisposition to malignant hyperthermia. BMC Med Genet 2009; 10: 104.","journal-title":"BMC Med Genet"},{"key":"9494_CR19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bja\/86.2.283","volume":"86","author":"A Urwyler","year":"2001","unstructured":"Urwyler A, Deufel T, McCarthy T, West S, European Malignant Hyperthermia Group. Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia. Br J Anaesth 2001; 86: 283-7.","journal-title":"Br J Anaesth"},{"key":"9494_CR20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/0310057X0803600311","volume":"36","author":"RL Gillies","year":"2008","unstructured":"Gillies RL, Bjorksten AR, Davis M, Du Sart D. Identification of genetic mutations in Australian malignant hyperthermia families using sequencing of RYR1 hotspots. Anaesth Intensive Care 2008; 36: 391-403.","journal-title":"Anaesth Intensive Care"},{"key":"9494_CR21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1213\/00000539-198910000-00015","volume":"69","author":"MG Larach","year":"1989","unstructured":"Larach MG. Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group. Anesth Analg 1989; 69: 511-5.","journal-title":"Anesth Analg"},{"key":"9494_CR22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF03005702","volume":"23","author":"BA Britt","year":"1976","unstructured":"Britt BA, Endrenyi L, Peters PL, Kwong FH, Kadijevic L. Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations. Can Anaesth Soc J 1976; 23: 263-84.","journal-title":"Can Anaesth Soc J"},{"key":"9494_CR23","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/bja\/aep204","volume":"103","author":"D Carpenter","year":"2009","unstructured":"Carpenter D, Robinson RL, Quinnell RJ, et al. Genetic variation in RYR1 and malignant hyperthermia phenotypes. Br J Anaesth 2009; 103: 538-48.","journal-title":"Br J Anaesth"},{"key":"9494_CR24","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","volume":"80","author":"MG Larach","year":"1994","unstructured":"Larach MG, Localio AR, Allen GC, et al. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology 1994; 80: 771-9.","journal-title":"Anesthesiology"},{"key":"9494_CR25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","volume":"162","author":"P Chomczynski","year":"1987","unstructured":"Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.","journal-title":"Anal Biochem"},{"key":"9494_CR26","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.","journal-title":"Nucleic Acids Res"},{"key":"9494_CR27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00000542-200308000-00010","volume":"99","author":"N Kraev","year":"2003","unstructured":"Kraev N, Loke JC, Kraev A, MacLennan DH. Protocol for the sequence analysis of ryanodine receptor subtype 1 gene transcripts from human leukocytes. Anesthesiology 2003; 99: 289-96.","journal-title":"Anesthesiology"},{"key":"9494_CR28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7: 248-9.","journal-title":"Nat Methods"},{"key":"9494_CR29","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009; 4: 1073-81.","journal-title":"Nat Protoc"},{"key":"9494_CR30","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/prot.20252","volume":"57","author":"C Ferrer-Costa","year":"2004","unstructured":"Ferrer-Costa C, Orozco M, de la Cruz X. Sequence-based prediction of pathological mutations. Proteins 2004; 57: 811-9.","journal-title":"Proteins"},{"key":"9494_CR31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.genom.7.080505.115630","volume":"7","author":"PC Ng","year":"2006","unstructured":"Ng PC, Henikoff S. Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet 2006; 7: 61-80.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"9494_CR32","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000542-200606000-00008","volume":"104","author":"MC Ibarra","year":"2006","unstructured":"Ibarra MC, Wu S, Murayama K, et al. Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing. Anesthesiology 2006; 104: 1146-54.","journal-title":"Anesthesiology"},{"key":"9494_CR33","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1212\/WNL.59.2.284","volume":"59","author":"H Jungbluth","year":"2002","unstructured":"Jungbluth H, Muller CR, Halliger-Keller B, et al. Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores. Neurology 2002; 59: 284-7.","journal-title":"Neurology"},{"key":"9494_CR34","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1590\/S0100-879X2009007500011","volume":"42","author":"AR Matos","year":"2009","unstructured":"Matos AR, Sambuughin N, Rumjanek FD, et al. Multigenerational Brazilian family with malignant hyperthermia and a novel mutation in the RYR1 gene. Braz J Med Biol Res 2009; 42: 1218-24.","journal-title":"Braz J Med Biol Res"},{"key":"9494_CR35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0960-8966(02)00218-3","volume":"13","author":"MR Davis","year":"2003","unstructured":"Davis MR, Haan E, Jungbluth H, et al. Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene. Neuromuscul Disord 2003; 13: 151-7.","journal-title":"Neuromuscul Disord"},{"key":"9494_CR36","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000542-199803000-00006","volume":"88","author":"GC Allen","year":"1998","unstructured":"Allen GC, Larach MG, Kunselman AR. The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS. Anesthesiology 1998; 88: 579-88.","journal-title":"Anesthesiology"},{"key":"9494_CR37","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1399-6576.1997.tb04820.x","volume":"41","author":"H Ording","year":"1997","unstructured":"Ording H, Brancadoro V, Cozzolino S, et al. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand 1997; 41: 955-66.","journal-title":"Acta Anaesthesiol Scand"},{"key":"9494_CR38","doi-asserted-by":"crossref","first-page":"16725","DOI":"10.1073\/pnas.012688999","volume":"99","author":"GG Du","year":"2002","unstructured":"Du GG, Sandhu B, Khanna VK, Guo XH, MacLennan DH. Topology of the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum (RyR1). Proc Natl Acad Sci USA 2002; 99: 16725-30.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9494_CR39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1254\/jjp.88.159","volume":"88","author":"H Oyamada","year":"2002","unstructured":"Oyamada H, Oguchi K, Saitoh N, et al. Novel mutations in C-terminal channel region of the ryanodine receptor in malignant hyperthermia patients. Jpn J Pharmacol 2002; 88: 159-66.","journal-title":"Jpn J Pharmacol"},{"key":"9494_CR40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/humu.20231","volume":"26","author":"N Monnier","year":"2005","unstructured":"Monnier N, Kozak-Ribbens G, Krivosic-Horber R, et al. Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility. Hum Mutat 2005; 26: 413-25.","journal-title":"Hum Mutat"},{"key":"9494_CR41","doi-asserted-by":"crossref","first-page":"51693","DOI":"10.1074\/jbc.M310406200","volume":"278","author":"M Stange","year":"2003","unstructured":"Stange M, Xu L, Balshaw D, Yamaguchi N, Meissner G. Characterization of recombinant skeletal muscle (Ser-2843) and cardiac muscle (Ser-2809) ryanodine receptor phosphorylation mutants. J Biol Chem 2003; 278: 51693-702.","journal-title":"J Biol Chem"},{"key":"9494_CR42","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1083\/jcb.200211012","volume":"160","author":"S Reiken","year":"2003","unstructured":"Reiken S, Lacampagne A, Zhou H, et al. PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle: defective regulation in heart failure. J Cell Biol 2003; 160: 919-28.","journal-title":"J Cell Biol"},{"key":"9494_CR43","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1136\/jmg.2003.014274","volume":"41","author":"S Shepherd","year":"2004","unstructured":"Shepherd S, Ellis F, Halsall J, Hopkins P, Robinson R. RYR1 mutations in UK central core disease patients: more than just the C-terminal transmembrane region of the RYR1 gene. J Med Genet 2004; 41: e33.","journal-title":"J Med Genet"},{"key":"9494_CR44","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/S0006-3495(03)75071-1","volume":"84","author":"CF Perez","year":"2003","unstructured":"Perez CF, Voss A, Pessah IN, Allen PD. RyR1\/RyR3 chimeras reveal that multiple domains of RyR1 are involved in skeletal-type E\u2013C coupling. Biophys J 2003; 84: 2655-63.","journal-title":"Biophys J"},{"key":"9494_CR45","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1373\/49.5.761","volume":"49","author":"A Tammaro","year":"2003","unstructured":"Tammaro A, Bracco A, Cozzolino S, et al. Scanning for mutations of the ryanodine receptor (RYR1) gene by denaturing HPLC: detection of three novel malignant hyperthermia alleles. Clin Chem 2003; 49: 761-8.","journal-title":"Clin Chem"},{"key":"9494_CR46","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1034\/j.1399-6576.2002.460610.x","volume":"46","author":"H Rueffert","year":"2002","unstructured":"Rueffert H, Olthoff D, Deutrich C, Meinecke CD, Froster UG. Mutation screening in the ryanodine receptor 1 gene (RYR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations. Acta Anaesthesiol Scand 2002; 46: 692-8.","journal-title":"Acta Anaesthesiol Scand"},{"key":"9494_CR47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1098-1004(1998)11:1<45::AID-HUMU7>3.0.CO;2-K","volume":"11","author":"BM Manning","year":"1998","unstructured":"Manning BM, Quane KA, Lynch PJ, et al. Novel mutations at a CpG dinucleotide in the ryanodine receptor in malignant hyperthermia. Hum Mutat 1998; 11: 45-50.","journal-title":"Hum Mutat"},{"key":"9494_CR48","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/humu.20696","volume":"29","author":"N Monnier","year":"2008","unstructured":"Monnier N, Marty I, Faure J, et al. Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores. Hum Mutat 2008; 29: 670-8.","journal-title":"Hum Mutat"},{"key":"9494_CR49","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0002-9343(98)00108-9","volume":"104","author":"J Loke","year":"1998","unstructured":"Loke J, MacLennan DH. Malignant hyperthermia and central core disease: disorders of Ca2+ release channels. Am J Med 1998; 104: 470-86.","journal-title":"Am J Med"},{"key":"9494_CR50","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1113\/jphysiol.2009.171967","volume":"587","author":"F Protasi","year":"2009","unstructured":"Protasi F, Paolini C, Dainese M. Calsequestrin-1: a new candidate gene for malignant hyperthermia and exertional\/environmental heat stroke. J Physiol 2009; 587: 3095-100.","journal-title":"J Physiol"}],"container-title":["Canadian Journal of Anesthesia\/Journal canadien d'anesth\u00e9sie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-011-9494-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12630-011-9494-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-011-9494-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T11:04:03Z","timestamp":1560078243000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12630-011-9494-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,31]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["9494"],"URL":"https:\/\/doi.org\/10.1007\/s12630-011-9494-6","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,31]]}}}